Trifecta-Lung cfDNA-MMDx Study
ConditionLung Transplantation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Alberta
About this trial
Demonstrate the relationship between dd-cfDNA levels and HLA antibodies in blood transplant recipient and Demonstrate the Molecular Microscope® (MMDx) Diagnostic System results in indication and protocol biopsies from lung transplants.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
19Australia
The Alfred Hospital, Monash University Melbourne Australia
Austria
Department of Thoracic Surgery, Medical University of Vienna Vienna Austria
Canada
Alberta Transplant Applied Genomics Centre, University of AlbertaT^g 2E1, EdmontonAlberta, Canada
Department of Medicine, University of AlbertaT6G 2G3, EdmontonAlberta, Canada
Sponsors and collaborators
University of Alberta
Lead sponsor
Natera, Inc.
Collaborator
One Lambda
Collaborator
Source ClinicalTrials.gov